Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Piro

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Seminars in Hematology|January 1, 1996
Cladribine in the treatment of low-grade non-Hodgkin's lymphomaL D Piro
Seminars in Hematology|October 1, 1993
2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphomaL D Piro
Oncology (Williston Park, N.Y.)|January 18, 2005
Apoptosis, Bcl-2 antisense, and cancer therapyLawrence D Piro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Purine nucleoside therapy of low-grade follicular lymphomaL D Piro
Blood|February 15, 1992
2-Chlorodeoxyadenosine treatment of lymphoid malignanciesL D Piro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
2-Chlorodeoxyadenosine: drug development prioritiesL D Piro
Panminerva Medica|March 1, 1993
Mono-octanoin and methyl tert-butyl ether mixture for bile duct stonesR Tritapepe, D Piro
Leukemia & Lymphoma|January 1, 1993
2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia and chronic lymphocytic leukemiaA Saven, L D Piro
Cancer|December 1, 1993
The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignanciesA Saven, L D Piro
Hematology and Cell Therapy|December 1, 1996
2-Chlorodeoxyadenosine: a potent antimetabolite with major activity in the treatment of indolent lymphoproliferative disordersA Saven, L D Piro
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Seminars in Hematology|January 1, 1996
Cladribine in the treatment of low-grade non-Hodgkin's lymphomaL D Piro
Seminars in Hematology|October 1, 1993
2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphomaL D Piro
Oncology (Williston Park, N.Y.)|January 18, 2005
Apoptosis, Bcl-2 antisense, and cancer therapyLawrence D Piro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Purine nucleoside therapy of low-grade follicular lymphomaL D Piro
Blood|February 15, 1992
2-Chlorodeoxyadenosine treatment of lymphoid malignanciesL D Piro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
2-Chlorodeoxyadenosine: drug development prioritiesL D Piro
Panminerva Medica|March 1, 1993
Mono-octanoin and methyl tert-butyl ether mixture for bile duct stonesR Tritapepe, D Piro
Leukemia & Lymphoma|January 1, 1993
2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia and chronic lymphocytic leukemiaA Saven, L D Piro
Cancer|December 1, 1993
The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignanciesA Saven, L D Piro
Hematology and Cell Therapy|December 1, 1996
2-Chlorodeoxyadenosine: a potent antimetabolite with major activity in the treatment of indolent lymphoproliferative disordersA Saven, L D Piro
Pageof 9